LoginSignup
Amneal logo

Amneal

Stock
Stock
ISIN: US03168L1052
Ticker: AMRX
US03168L1052
AMRX

Price

Price

CHART BY

Frequently asked questions

What is Amneal's market capitalization?

The market capitalization of Amneal is $2.41B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Amneal?

Amneal's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.685. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Amneal's stock?

Currently, 4 analysts cover Amneal's stock, with a consensus target price of $10.50. Analyst ratings provide insights into the stock's expected performance.

What is Amneal's revenue over the trailing twelve months?

Over the trailing twelve months, Amneal reported a revenue of $2.68B.

What is the EBITDA for Amneal?

Amneal's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $571.20M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Amneal?

Amneal has a free cash flow of $101.30M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Amneal have, and what sector and industry does it belong to?

Amneal employs approximately 7,850 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of Amneal's shares?

The free float of Amneal is 126.70M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$2.41B
EPS (TTM) 
-$0.685
Free Float 
126.70M
Revenue (TTM) 
$2.68B
EBITDA (TTM) 
$571.20M
Free Cashflow (TTM) 
$101.30M

Pricing

1D span
$7.614$7.848
52W span
$5.01$9.47

Analyst Ratings

The price target is $10.50 and the stock is covered by 4 analysts.

Buy

3

Hold

1

Sell

0

Information

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Employees
7,850
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
US03168L1052
Primary Ticker
AMRX

Knockouts

Join the conversation
Sign upLogin